These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1979175)

  • 1. Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.
    Allard P; Eriksson K; Ross SB; Marcusson JO
    Psychopharmacology (Berl); 1990; 102(3):291-4. PubMed ID: 1979175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period.
    Shi X; Yin R; Dow-Edwards D
    Eur J Pharmacol; 1999 Apr; 370(3):241-9. PubMed ID: 10334498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration.
    Hitri A; Little KY; Ellinwood EH
    Neuropsychopharmacology; 1996 Mar; 14(3):205-10. PubMed ID: 8866704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M; Hidaka K; Nakamura Y
    Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
    Ogren SO; Rosén L; Fuxe K
    Neuroscience; 1994 Jul; 61(2):269-83. PubMed ID: 7969908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
    Ericson H; Ross SB
    Eur J Pharmacol; 1992 Jun; 226(2):157-61. PubMed ID: 1353452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME; Narang N; Wamsley JK
    Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats.
    Hillegaart V; Ahlenius S; Fowler CJ; Magnusson O
    Pharmacol Toxicol; 1988 Aug; 63(2):114-7. PubMed ID: 3186617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens.
    Berger P; Elsworth JD; Arroyo J; Roth RH
    Eur J Pharmacol; 1990 Feb; 177(1-2):91-4. PubMed ID: 1967129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic modification of dopaminergic transmission and its effects on binding characteristics of dopamine transporter ligand 3H-GBR 12783 in the striatum.
    Valchár M; Bonnet JJ; Costentin J
    Act Nerv Super (Praha); 1989 Dec; 31(4):273-4. PubMed ID: 2561622
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ; Marshall JF
    Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: III. Dopamine uptake.
    Lim DK; Yu ZJ; Hoskins B; Rockhold RW; Ho IK
    Neurochem Res; 1990 Jun; 15(6):629-34. PubMed ID: 2215854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.